You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Immune checkpoint inhibitor plus tyrosine kinase inhibitor with or without transarterial chemoembolization for unresectable hepatocellular carcinoma
- 2. Histogram analysis of multiple mathematical diffusion-weighted imaging models for preoperative prediction of Ki-67 expression in hepatocellular carcinoma
- 3. Nwd1 gene deletion triggers MASH-like pathology in mice
- 4. Unlocking the hidden proteome: The role of coding circular RNA in cancer
- 5. How environmental exposures affect genes and increase cancer risk
- 6. Secret boss of the liver: Star-shaped cells that promote fibrosis also regulate liver health
- 7. Prostate cancer is not a death knell, study shows
- 8. Pfizer and Arvinas's HER2-breast cancer drug extends PFS in certain patients
- 9. Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035
- 10. Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study
Last updated at 6:21 GMT
Hot News Makers
Health/Pharma Companies
-
27926.42
-
6280.01
-
3751.95
-
3117.55
-
3115.65
-
2444.48
-
2014.23
-
1224.44
-
1166.44
-
1130.47
Drugs, Treatments, Trials
-
5500.54
-
3912.16
-
2959.69
-
2279.42
-
1353.00
-
1112.29
-
943.95
-
650.41
-
572.51
-
369.34
Last updated at 6:10 GMT
